Omnicell (NASDAQ:OMCL – Get Free Report) will release its earnings data before the market opens on Wednesday, October 30th. Analysts expect Omnicell to post earnings of $0.41 per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.
Omnicell (NASDAQ:OMCL – Get Free Report) last released its earnings results on Thursday, August 1st. The company reported $0.51 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.37. Omnicell had a negative net margin of 1.92% and a positive return on equity of 2.52%. The firm had revenue of $276.80 million for the quarter, compared to analyst estimates of $254.41 million. During the same period in the prior year, the firm earned $0.29 earnings per share. The business’s quarterly revenue was down 7.4% compared to the same quarter last year. On average, analysts expect Omnicell to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Omnicell Stock Performance
NASDAQ OMCL opened at $39.50 on Monday. The company has a fifty day moving average of $43.04 and a two-hundred day moving average of $34.71. The company has a market capitalization of $1.81 billion, a PE ratio of -85.87, a P/E/G ratio of 45.31 and a beta of 0.83. Omnicell has a 1 year low of $25.12 and a 1 year high of $45.84. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.45 and a quick ratio of 2.22.
Analyst Ratings Changes
Check Out Our Latest Analysis on OMCL
About Omnicell
Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.
See Also
- Five stocks we like better than Omnicell
- Options Trading – Understanding Strike Price
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- 3 Fintech Stocks With Good 2021 Prospects
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- The How And Why of Investing in Oil Stocks
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Omnicell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell and related companies with MarketBeat.com's FREE daily email newsletter.